Within a large clonal population, such as cancerous tumor entities, cells are not identical, and the differences of intracellular pH levels of individual cells may be important indicators of heterogeneity that could be relevant in clinical practice, especially in personalized medicine.
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Personalized medicine holds great potential, especially in treating cancer, which remains a major medical challenge due to both intrinsic and acquired resistance to conventional chemotherapeutics [1] [2] [3] . In the last decade, advances have been made in the development of personalized cancer therapeutics to increase the efficacy of chemotherapy 4 . Despite every effort to tailor drugs to the individual, results vary 5 . This fact has been correlated with the presence of genetically distinct cells within an individual tumor 6 . In recent studies genome sequencing technology has been employed to identify these genetic alterations in a large population of cells [7] [8] [9] . While genetic aspects of cancer cell heterogeneity and the relationship between mutations and drug resistance have been studied extensively, development of prescreening technologies to detect heterogeneity, that is, to find cancer cells that differ in their cellular metabolism and physiology within large cell populations, is under-investigated.
Evaluation of cells heterogeneity can be performed through the measurement of cytoplasmic ions and molecules. Accumulation of metal ions 10 , changes in reactive oxygen (ROS) and nitrogen species (RNS) levels 11 , and protein expression 12 are important markers of cancerous cells within cell populations. Although less recognized, pH is also a distinctive factor of cancer cells. pH is one of the most intriguing features in initiating and regulating a myriad of cellular events, such as multi-drug resistance in tumor 13 , protein processing 14 , endocytosis 15 and apoptosis 16 . Due to its vital importance, the pH of the intracellular environment is strictly regulated through various ion channels and intracellular weak acids and bases, such as alkali cation-H + exchangers, bicarbonate and acid loading transporters. In mammalian cells, subcellular compartments have different pH values in order to sustain optimum operational conditions for certain metabolic functions 17 . In normal physiological conditions, the resting intracellular pH of mammalian cells is maintained between 6.8 and 7. 
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resistance, and is observed in cancerous tumors 19 . Moreover pH has a great effect on tumor growth and cancer cell migration and therefore the potential for metastases 20, 21 .
Carcinogenic tumors are heterogeneous and widely assumed to be acidic due to the high metabolic rate of cancer cells coupled with poor blood supply. This regional high metabolism and lack of perfusion triggers an anaerobic metabolism which leads extracellular pH levels to decrease to ~6.0 22 . Additionally, aerobic metabolism can increase the intracellular concentration of carbon dioxide (CO 2 ), which results in a decrease of local pH levels. These two mechanisms of acidification are commonly accepted in cancer research. Little is known, however, about whether intracellular pH levels contribute to intratumoral heterogeneity, and if it is an indicator of preexisting metabolic heterogeneity in cancer cells in a large cell population. Greater granularity of pH data will be of great importance not only for the development of new anti-cancer drugs and carriers, as most of new drug delivery systems propose to use pH sensitive polymers or pH sensitive polymeric nanoparticles, but also to ascertain how effectively anti-cancer drug work over the course of treatment. Therefore, real-time quantitative measurement of intracellular pH may be crucial to link intratumoral cell heterogeneity, drug resistance and drug delivery systems for effective treatment.
pH can be used as a marker for the identification of variants of cancer cells in a tumor tissue.
Once identified, these cells can be tagged and followed over the course of drug treatment. 
phosphorylation, and therefore it is important to measure pH and understand its effect on neural recovery at the damaged site of brain 23 . Additionally, cerebral pH has been found to be one of the major markers of metabolic disturbance and lethality after brain injury 24 . Many of these studies have suffered the lack of an appropriate analytical tool.
Commonly utilized analytical techniques to measure intracellular pH values include nuclear magnetic resonance (NMR) 25 , electrochemistry 26, 27 , confocal microscopy 28 , and absorbance and fluorescence spectroscopy [29] [30] [31] . Of these, fluorescence spectroscopy and imaging are the most widely used techniques. However fluorescence intensity is hard to quantify directly and suffers from the experimental factors such as dye localization, photobleaching, excitation wavelength and cellular uptake and release rate. Additionally, fluorescence intensity can be affected by autofluorescence. Moreover, fluorescence probes do not allow continuous and site-specific detection of intracellular pH levels.
Here, we report the development of a nano-sized pH probe based on ionic conductance technique to measure pH at the single-cell level. This new nano-pH probe can be used as an analytical tool to illuminate the relationship between pH and a variety of diseases. To solve the aforementioned issues we propose the use of nanopipette platform that utilizes scanning ion conductance microscopy (SICM) principles 32 . Nanopipettes are electrical devices that can measure the differences in ionic current at a nanopore. Their small sizes enables direct, realtime in vitro measurements with high spatial resolution and reduced invasiveness, allowing the monitoring of intracellular changes of an individual cell over the course of drug treatment. Recently, nanopipettes have gained importance as novel sensing tools and have been investigated for the detection of proteins 33, 34 , metal cations 32, 35 , DNA 36 and carbohydrates 37 . Quartz nanopipettes can be functionalized with various recognition materials. In this work chitosan, a biopolymer, is used as a pH-sensitive surface coating of internal surface of nanopipettes. Chitosan is biocompatible and has low-toxicity which makes it ideal for biological purposes. It possesses unique film-forming ability, high adherence to surfaces and remarkable mechanical strength. In addition, chitosan has been shown as a selective coating for biosensor fabrication [38] [39] [40] .
In this work, we demonstrate the development and characterization of chitosan-modified quartz nanopipettes for pH measurements in physiological buffers and cell media. We then used the chitosan-modified nanopipettes for the direct measurement of intracellular pH at four different cells types, including human fibroblast, HeLa, MCF-7 and MDA-MB-231. We evaluated the in vitro specificity of chitosan-modified nano-pH probes using a chloride channel blocker. The nano-pH probe is a powerful candidate not only to investigate cell heterogeneity in a variety of pathologic states, including cancerous tumors, but also neurodegenerative states and aging.
Materials and Methods

Reagents and materials
Chitosan (low molecular weight), Dulbecco's modified eagle medium (DMEM) and trypsin were purchased from CellGro while fetal bovine serum (FBS) and penicillin-streptomycin from Gibco. All aqueous solutions are prepared in distilled, deionized water (Millipore, Synthesis System) with a resistivity of 18.2 Ω cm.
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Preparation of nano-pH probe
Nanopipettes were fabricated from quartz capillaries with filament (QF100-70. 
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For intracellular pH buffer calibration, cell cultures were exposed to complete pH calibration buffer prepared according to the protocol supplied with the Intracellular pH Calibration Buffer Kit (Life Technologies, P35379), and were incubated at 37⁰C for 10 min before imaging. Intracellular pH calibration was done in three replicates. All fluorescence microscopy analyses were carried out with a Leica SP5 confocal microscope using the Leica Application Suite Advance Fluorescence (LAS AF 3) software. Further image analyses were performed with Fiji-ImageJ software.
Results & Discussion
Characterization of pH-responsive quartz nanopipette sensors
The measurement principle of nanopipettes is based on the ionic current at tip. This ionic current is highly dependent on the pore size and surface charge of nanopipette 34 . The surface charge of a quartz nanopipette is negative due to dissociation of silanol groups at the glassliquid interface. Quartz undergoes protonation at extremely acidic pH values 41 . These surface properties of quartz reduce pH sensing capabilities, making bare nanopipettes inappropriate for measuring very small pH changes. Limitations associated with the low sensitivity of bare quartz surfaces can be overcome through the incorporation of pH responsive polymeric entities onto nanopipette surfaces. Here, we employed chitosan as the pH sensitive surface coating. Chitosan, with a strong positive charge at acidic pH, is attracted to hydroxyl moieties on the negatively charged quartz surface through electrostatic interactions. In addition to alterations of the surface charge, the thickness of the chitosan layer has been shown to change with pH which may enhance the sensitivity of the nanopipette 42, 43 . To evaluate the presence and impact of the chitosan layer on the nanopipette surface, we monitored the changes in current responses as a result of surface modification. Figure 1A 
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The recorded current response significantly decreases after chitosan modification. To optimize the sensitivity of the nano-pH sensor, various concentrations of chitosan were studied (supplementary information (SI) Figure SI1 ). Due to viscous properties and limited tip-geometry, high concentrations of chitosan solutions did not reach to the nanopore. Typical geometric shape of a nanopipette tip is conical (Figure SI2A) , and the pore size of quartz nanopipettes were determined by SEM and found to be ~ 97 nm ( Figure 1B) . Additional SEM micrographs were taken to further confirm the presence of the chitosan layer ( Figure   SI2B ). Because the chitosan modification was done on the inside of the nanopipette, a are distinct breast cancer cell lines. MCF-7 is a hormone-responsive cell line and its growth is stimulated with estrogen; MDA-MB-231 derives from an invasive breast cancer which was found to be highly metastatic 45 . We chose to interrogate these two breast cancer cell lines because they exhibit different drug sensitivities and we sought to determine whether this could be correlated with differences in the intracellular pH levels.
Chitosan-modified nanopipettes were inserted to individual cells using a customized scanning ion conductance microscope which detects current feedback for positioning the nanopipettes.
Recently we have demonstrated that this custom-built platform can perform nanobiopsies at the single-cell level for genomic investigations 46 . Figure SI9A Figure 4A ). The observed intracellular pH level in these human fibroblasts is in line with previous reports estimating pH levels through indirect and destructive approaches, including monitoring of ion exchangers (NHEs and NBCs) and acid transporters (AEs) 17 .
We also used the nano-pH probes to investigate the metabolic differences between noncancerous and cancerous cells. As cancer cells have a faster metabolic rate compared to noncancerous cells, production of acidic species and CO 2 in cancer cells is higher as well. Using the chitosan-modified nano-pH probe in 14 individual HeLa cells for intracellular pH measurements, we found the average pH for HeLa cells to be 6.75 ± 0.27 ( Figure 4B ).
Figure 4 Intracellular pH levels of individual cells determined by chitosan-modified nanopipettes. pH levels recorded for (A) human fibroblast, (B) HeLa, (C) MCF-7 and (D)
MDA-MB-231 cells. Horizontal lines represent the average intracellular pH measured with the nano-pH probe.
To compare whether a similarly acidic intracellular environment is present in other cancer cell lines, we performed pH measurements on breast cancer lines. Using the nano-pH probe, To fully deploy the pH nano-probe, we intend to build a fully-automated high-throughput robotic system that will allow us to interrogate hundreds of cells in a range of minutes. Cells having lower or higher pH values compared to the general population of cells will be 
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identified and then tagged with a molecular marker to nanobiopsy for DNA and RNA sequencing.
Pharmaceutical manipulation of intracellular pH
Of its many possible uses, we hope that the nano-pH probe can be used to monitor intracellular pH changes during drug therapy. To this end, we deployed the nano-pH probe 
Conclusions
Direct measurement of intracellular pH has been investigated for more than forty years 26, 27 .
We have achieved in a new way via simple physisorption of chitosan into a quartz nanopipette. Our approach takes advantage of a pH-responsive chitosan polymeric layer and the small size of a nanopipette for intracellular pH measurement at the single-cell level.
Leveraging a scanning ion conductance microscope customized for single-cell navigation, we were able to insert nano-pH probes into individual cells. In vitro results showed that chitosanfunctionalized nanopipettes measure intracellular pH selectively with high temporal resolution. The average intracellular pH levels were 7.37 ± 0.29, 6.75 ± 0.27, 6.91 ± 0.20 and 6.85 ± 0.11 for human fibroblast, HeLa, MCF-7 and MDA-MB-231, respectively. These Our data show that chitosan-modified nanopipette sensing technology is a powerful approach for interrogating single-cell pH levels with high spatial and temporal resolution with high selectivity and sensitivity. Further application of this nano-pH probe technology may provide a deeper understanding of cell heterogeneity and drug resistance. To achieve this aim, we are working on the development of a fully automated system for high-throughput screening of cell populations over the course of drug treatment. Additionally, we will use nano-pH probes to investigate pH changes and differences in tumorous microenvironments (e.g. tumor tissues). 
